Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
Short-term prognostic factors of rituximab combined with glucocorticoids in the treatment of pemphigus: A multicenter retrospective study. (PubMed, J Am Acad Dermatol) - Sep 17, 2026 - "This study identifies readily obtainable baseline predictors for CR mini and relapse in RTX-treated pemphigus, facilitating early risk stratification and individualized treatment strategies to optimize long-term outcomes." 
Biomarker • Journal • Retrospective data • Herpes Simplex • Infectious Disease
http://www.ncbi.nlm.nih.gov/pubmed/42749058
 
Cong Zhang; Feng Guo; Gang Hu; Guiying Zhang; Jiefeng Jiang; Jinbo Chen; Ruzeng Xue; ShuoMin Chen; Xueting Yang; Yiqian Peng; Yiu Nam; Zhili Wu
 
Sep 17, 2026
 
Prev Next